Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MoKA: Sub-Dissociative Ketamine vs Morphine in Children With Acute Pain
NCT06835504Phase 3Recruiting
- Sponsor
- Columbia University
- Start
- Oct 2026
- Primary completion
- Apr 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in acute pain, sponsored by Columbia University. Started Oct 2026; status: recruiting.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT06835504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06835504.